1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:


Clear current filters  or Add more filters

View Option


Results 1-10 of 11 (Search time: 0.013 seconds).

  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study (Journal article)

  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients (Journal article)

  Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT Analysis (Journal article)

  Should atenolol still be recommended as first-line therapy for primary hypertension? (Journal article)

  Targeting vascular risk in patients with metabolic syndrome but without diabetes (Journal article)

  Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels (Journal article)

  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? (Journal article)

  Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study (Journal article)

  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study (Journal article)

  Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort (Journal article)